# nference

> nference builds AI software that turns de-identified clinical notes, imaging, molecular data and patient histories into research-ready information. Its nSights platform serves life sciences researchers, while Nucleus helps organizations analyze their own clinical data. Long-term health system partnerships underpin its federated analytics network.

- **Founded:** 2013
- **Headquarters:** Cambridge, United States
- **Founders:** Murali Aravamudan (Co-Founder & Chief Executive Officer), Venky Soundararajan (Co-Founder & Chief Scientific Officer)
- **Products:** nSights, Nucleus, Federated Clinical Analytics Platform (FCAP), nferX
- **Notable:** Selected as Mayo Clinic’s first Clinical Data Analytics Platform partner in 2020., Co-founded ECG-AI company Anumana with Mayo Clinic in 2021., Founded digital pathology company Pramana in 2021; Evident announced its acquisition in August 2025, and nference now describes it as part of Evident.

## Products & services

- **nSights** — Real-world evidence platform for searching structured and unstructured de-identified clinical data, designing cohorts, exploring patient journeys, and developing research models.
- **Nucleus** — Clinical intelligence software deployed in an organization’s environment to connect, harmonize and analyze proprietary multimodal clinical and trial data.
- **Federated Clinical Analytics Platform (FCAP)** — Health system infrastructure for data harmonization, de-identification, augmented curation and federated research; nference states it funds deployment.
- **nferX** — Earlier biomedical knowledge synthesis platform described in company and Mayo announcements; uses neural networks to extract knowledge from biomedical literature.

## Achievements

- Selected as Mayo Clinic’s first Clinical Data Analytics Platform partner in 2020.
- Co-founded ECG-AI company Anumana with Mayo Clinic in 2021.
- Founded digital pathology company Pramana in 2021; Evident announced its acquisition in August 2025, and nference now describes it as part of Evident.
- Company website reports coverage of more than 40 million patient lives as of the research date.
- Company news page reports inclusion in TIME’s 2026 World’s Top HealthTech Companies for a second consecutive year.

## Latest updates

- **2026-09** — September 16: company reported a second consecutive appearance on TIME’s World’s Top HealthTech Companies list.
- **2026-09** — September 2: announced a long-term Rush collaboration to build a Rush-hosted clinical analytics platform.
- **2026-06** — June 9: announced publications from MAIA, its Metabolic Agentic Intelligence Atlas research initiative.
- **2025-08** — Evident announced an agreement to acquire Pramana, a digital pathology company founded by nference.
- **2025-04** — Announced a BeiGene collaboration on B-cell cancer research.

## Links

- Website: https://nference.com
- LinkedIn: https://www.linkedin.com/company/nference
- Twitter/X: https://x.com/_nference
- Facebook: https://facebook.com/nferencelabs/

---

Profile page: https://yespress.io/nference
Published by YesPress — https://yespress.io
Last updated: 2026-10-16